ReviewOncoTargets and therapy2017

Immunotargeting relapsed or refractory precursor B-cell acute lymphoblastic leukemia - role of blinatumomab.

Manon Queudeville et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.